Article
Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients.
Oral oncology - 1 Mar 2020
Ogi Kazuhiro, Kobayashi Junichi, Nakagaki Takafumi, Okamoto Junya, Koike Kazushige, Hirokawa Naoki, Someya Masanori, Sakamoto Hiroki, Takada Kohichi, Tokino Takashi, Sasaki Yasushi, Hiratsuka Hiroyoshi, Miyazaki Akihiro
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
